Are Chemical Risk Assessment and Benefit-Cost Analysis Compatible?
Executive Order 12866 requires benefit-cost analyses for all regulations; in many cases these economic analyses rely upon risk assessment for critical inputs. Usually this is not a problem; in principle, risk assessment and benefit-cost analysis are perfectly compatible.
Herding Genetically Engineered Animals to Market
FDA’s decision to approve a genetically engineered salmon for human consumption bodes well for people interested in cheaper fish.
Missed Opportunity for EPA to Cut Back Renewable Fuel Standard
Congress and EPA should reevaluate whether the Renewable Fuel Standard is accomplishing its goals.
OMB's 2015 Draft Report to Congress on the Benefits and Costs of Federal Regulations
Pursuant to the Regulatory Right-to-Know Act, the Office of Management and Budget (OMB) submits to Congress each year an accounting statement and associated report providing estimates of the total annual benefits and costs of federal regulations; an analysis of impacts of Federal regulation on State, local, and tribal government, small business, wages, and economic growth; and recommendations for reform.
Midnight Rules: A Comparison of Regulatory Output Across Administrations
Understanding Midnight Regulatory Activity and how it's used
The public policy world is not exempt misunderstandings, and the renewed emphasis on retrospective regulatory review is a case in point.
Political Discourse Includes Regulatory Reform
This commentary provides a brief review of what the 2016 presidential candidates have to say about regulatory reform.
Early Notice from U.S. Agencies Could Help Avoid Creating Barriers to Trade
Early Notice from U.S. Agencies Could Help Avoid Creating Barriers to Trade
Evaluating Retrospective Review of Regulations in 2014
President Obama has encouraged agencies to review existing regulations and to modify, streamline, expand, or repeal them.
